Next Article in Journal
Diagnostic Precision in Lyme borreliosis: Assessing VlsE and C6 Antigens in a Pediatric Cohort
Next Article in Special Issue
An Umbrella Review of the Fusion of fMRI and AI in Autism
Previous Article in Journal
Usefulness of Saline Sealing in Preventing Pneumothorax after CT-Guided Biopsies of the Lung
Previous Article in Special Issue
Fractional Flow Reserve-Based Patient Risk Classification
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Comment

AI-Enabled Fusion of Medical Imaging, Behavioral Analysis and Other Systems for Enhanced Autism Spectrum Disorder. Comment on Jönemo et al. Evaluation of Augmentation Methods in Classifying Autism Spectrum Disorders from fMRI Data with 3D Convolutional Neural Networks. Diagnostics 2023, 13, 2773

by
Daniele Giansanti
Centre Tisp, The Italian National Institute of Health, 00161 Rome, Italy
Diagnostics 2023, 13(23), 3545; https://doi.org/10.3390/diagnostics13233545
Submission received: 12 October 2023 / Accepted: 21 November 2023 / Published: 28 November 2023
(This article belongs to the Special Issue Artificial Intelligence in Clinical Medical Imaging)
I am writing to you in regard to the research articleJohan Jönemo, David Abramian, and Anders Eklund—Evaluation of Augmentation Methods in Classifying Autism Spectrum Disorders from fMRI Data with 3D Convolutional Neural Networks” [1].
In the Special Issues (SIs) that I coordinate, I always try to identify an article that stimulates a discussion with scholars for wide-ranging future development. In this SI [2], I identified your article. Autism, as a neurodevelopmental disorder, affects social behavior, communication and interaction. It manifests as difficulties in understanding other people’s emotions, as verbal and non-verbal communication, as restricted interest in certain topics and as the repetitiveness of behaviors and routines. Each autistic individual is unique in his or her characteristics and level of functioning [3]. The therapeutic approach varies depending on individual needs and often involves multidisciplinary interventions.
This uniqueness is reflected in the difficulty of diagnosis [4,5], which requires a multifaceted approach from different medical disciplines, and in treatment that increasingly highlights the need for personalized medicine dedicated to autism [6,7].
Among the important activities in diagnosis are the following [4,5]:
  • Observation and interviews;
  • Physical exams and medical history;
  • Developmental assessment and screening;
  • Psychological and psychomotor evaluation;
  • Assessment of social behavior and social interactions;
  • Language and communication assessment;
  • Sensory assessment;
  • Functional behavior assessment;
  • Genetic, metabolic, biochemical, immunological and neurobiological assessments;
  • Assessments of environmental factors;
  • Medical imaging assessment.
Functional Magnetic Resonance Imaging (fMRI) has played and is playing a significant role in advancing our understanding of autism spectrum disorder (ASD) by allowing researchers to investigate brain activity and connectivity in individuals with ASD. A search on PubMed with the composite key “Search: (fmri [Title/Abstract]) AND (autism [Title/Abstract]) Filters: Systematic Review Sort by: Publication Date” identified 14 systematic reviews starting from 2011, clearly identifying the potential of fMRI applied to autism, and also highlighting the need of an umbrella review [7,8,9,10,11,12,13,14,15,16,17,18,19,20,21]. fMRI allows, for example, for functional connectivity studies, Resting State fMRI (rs-fMRI), Task-Based fMRI, the neural correlation of social and communication impairments, and sensory processing and sensory integration investigation. Furthermore longitudinal fMRI studies can track brain development and changes in connectivity patterns over time in individuals with autism, which is very useful for understanding how the brain develops in those with ASD and how this leads to behavioral and cognitive changes. In fMRI, Machine Learning and Predictive Modeling have shown potential in earlier and more precise diagnosis and also in identifying specific biomarkers. Progress due to personalized interventions and therapies can be monitored just by means of fMRI, a useful tool to assess effectiveness in this filed.
I found your study very interesting and attractive.
I believe that, as you have highlighted, 3D augmentation techniques together with artificial intelligence (AI) applied to fMRI are promising.
I believe that this is a line of research that should be insisted upon.
I would also like to discuss with you the evolution prospects.
It is clear that autism requires a multidisciplinary approach and represents an area in which personalized medicine (PM) can undergo important development.
Multiple diagnostic approaches also play an important role in PM as in autism.
fMRI certainly has a key role and 3D augmentation and can represent a further boost in diagnosis and classification. AI is increasingly helping us in all of this, allowing for the classification of increasingly important volumes of data.
Personally, among the development directions of your study, I see potential in the application of AI tools to data reservoirs that, in the future, could include both the 3D-augmentation-based imaging method proposed by you and data coming from the many other multifaceted diagnostic activities not based on imaging.
I would like this comment open a scientific discussion with scholars as I am increasingly convinced that fMRI has been instrumental in uncovering the neural underpinnings of autism, shedding light on altered brain connectivity, social and sensory processing differences, and potential biomarkers; therefore, all the tools (and therefore, also the AI-based tools) integrating fMRI findings with other research approaches could contribute to a comprehensive understanding of autism and open the door to targeted interventions and treatments.

Conflicts of Interest

The author declares no conflict of interest.

References

  1. Jönemo, J.; Abramian, D.; Eklund, A. Evaluation of Augmentation Methods in Classifying Autism Spectrum Disorders from fMRI Data with 3D Convolutional Neural Networks. Diagnostics 2023, 13, 2773. [Google Scholar] [CrossRef] [PubMed]
  2. Available online: https://www.mdpi.com/journal/diagnostics/special_issues/3FXN9682V0 (accessed on 15 November 2023).
  3. Available online: https://www.cdc.gov/ncbddd/autism/screening.html#:~:text=Diagnosing%20autism%20spectrum%20disorder%20(ASD,months%20of%20age%20or%20younger (accessed on 15 November 2023).
  4. Available online: https://www.cdc.gov/ncbddd/autism/hcp-dsm.html (accessed on 15 November 2023).
  5. Lord, C.; Elsabbagh, M.; Baird, G.; Veenstra-Vanderweele, J. Autism spectrum disorder. Lancet 2018, 392, 508–520. [Google Scholar] [CrossRef] [PubMed]
  6. National Institute of Mental Health. A Parent’s Guide to Autism Spectrum Disorder. 2011. Available online: http://www.nimh.nih.gov/health/publications/a-parents-guide-to-autism-spectrum-disorder/index.shtml (accessed on 8 March 2012).
  7. Kotte, A.; Joshi, G.; Fried, R.; Uchida, M.; Spencer, A.; Woodworth, K.Y.; Kenworthy, T.; Faraone, S.V.; Biederman, J. Autistic traits in children with and without ADHD. Pediatrics 2013, 132, e612–e622. [Google Scholar] [CrossRef] [PubMed]
  8. Morrel, J.; Singapuri, K.; Landa, R.J.; Reetzke, R. Neural correlates and predictors of speech and language development in infants at elevated likelihood for autism: A systematic review. Front. Hum. Neurosci. 2023, 17, 1211676. [Google Scholar] [CrossRef] [PubMed]
  9. Xiao, J.; Wu, J. Effectiveness of the Neuroimaging Techniques in the Recognition of Psychiatric Disorders: A Systematic Review and Meta-analysis of RCTs. Curr. Med. Imaging 2023, 20, e260523217379. [Google Scholar] [CrossRef]
  10. Kangarani-Farahani, M.; Izadi-Najafabadi, S.; Zwicker, J.G. How does brain structure and function on MRI differ in children with autism spectrum disorder, developmental coordination disorder, and/or attention deficit hyperactivity disorder? Int. J. Dev. Neurosci. 2022, 82, 681–715. [Google Scholar] [CrossRef] [PubMed]
  11. Fathabadipour, S.; Mohammadi, Z.; Roshani, F.; Goharbakhsh, N.; Alizadeh, H.; Palizgar, F.; Cumming, P.; Michel, T.M.; Vafaee, M.S. The neural effects of oxytocin administration in autism spectrum disorders studied by fMRI: A systematic review. J. Psychiatr. Res. 2022, 154, 80–90. [Google Scholar] [CrossRef] [PubMed]
  12. Santana, C.P.; de Carvalho, E.A.; Rodrigues, I.D.; Bastos, G.S.; de Souza, A.D.; de Brito, L.L. rs-fMRI and machine learning for ASD diagnosis: A systematic review and meta-analysis. Sci. Rep. 2022, 12, 6030. [Google Scholar] [CrossRef] [PubMed]
  13. Miranda, L.; Paul, R.; Pütz, B.; Koutsouleris, N.; Müller-Myhsok, B. Systematic Review of Functional MRI Applications for Psychiatric Disease Subtyping. Front. Psychiatry 2021, 12, 665536. [Google Scholar] [CrossRef] [PubMed]
  14. Walsh, M.J.M.; Wallace, G.L.; Gallegos, S.M.; Braden, B.B. Brain-based sex differences in autism spectrum disorder across the lifespan: A systematic review of structural MRI, fMRI, and DTI findings. Neuroimage Clin. 2021, 31, 102719. [Google Scholar] [CrossRef] [PubMed]
  15. Kohl, S.H.; Mehler, D.M.A.; Lührs, M.; Thibault, R.T.; Konrad, K.; Sorger, B. The Potential of Functional Near-Infrared Spectroscopy-Based Neurofeedback-A Systematic Review and Recommendations for Best Practice. Front. Neurosci. 2020, 14, 594, Erratum in Front. Neurosci. 2022, 16, 907941. [Google Scholar] [CrossRef] [PubMed]
  16. Lukito, S.; Norman, L.; Carlisi, C.; Radua, J.; Hart, H.; Simonoff, E.; Rubia, K. Comparative meta-analyses of brain structural and functional abnormalities during cognitive control in attention-deficit/hyperactivity disorder and autism spectrum disorder. Psychol. Med. 2020, 50, 894–919. [Google Scholar] [CrossRef] [PubMed]
  17. Clements, C.C.; Zoltowski, A.R.; Yankowitz, L.D.; Yerys, B.E.; Schultz, R.T.; Herrington, J.D. Evaluation of the Social Motivation Hypothesis of Autism: A Systematic Review and Meta-analysis. JAMA Psychiatry 2018, 75, 797–808. [Google Scholar] [CrossRef] [PubMed]
  18. Wigton, R.; Radua, J.; Allen, P.; Averbeck, B.; Meyer-Lindenberg, A.; McGuire, P.; Shergill, S.S.; Fusar-Poli, P. Neurophysiological effects of acute oxytocin administration: Systematic review and meta-analysis of placebo-controlled imaging studies. J. Psychiatry Neurosci. 2015, 40, E1–E22. [Google Scholar] [CrossRef] [PubMed]
  19. Hamilton, A.F. Reflecting on the mirror neuron system in autism: A systematic review of current theories. Dev. Cogn. Neurosci. 2013, 3, 91–105. [Google Scholar] [CrossRef] [PubMed]
  20. Philip, R.C.; Dauvermann, M.R.; Whalley, H.C.; Baynham, K.; Lawrie, S.M.; Stanfield, A.C. A systematic review and meta-analysis of the fMRI investigation of autism spectrum disorders. Neurosci. Biobehav. Rev. 2012, 36, 901–942. [Google Scholar] [CrossRef] [PubMed]
  21. Sugranyes, G.; Kyriakopoulos, M.; Corrigall, R.; Taylor, E.; Frangou, S. Autism spectrum disorders and schizophrenia: Meta-analysis of the neural correlates of social cognition. PLoS ONE 2011, 6, e25322. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Giansanti, D. AI-Enabled Fusion of Medical Imaging, Behavioral Analysis and Other Systems for Enhanced Autism Spectrum Disorder. Comment on Jönemo et al. Evaluation of Augmentation Methods in Classifying Autism Spectrum Disorders from fMRI Data with 3D Convolutional Neural Networks. Diagnostics 2023, 13, 2773. Diagnostics 2023, 13, 3545. https://doi.org/10.3390/diagnostics13233545

AMA Style

Giansanti D. AI-Enabled Fusion of Medical Imaging, Behavioral Analysis and Other Systems for Enhanced Autism Spectrum Disorder. Comment on Jönemo et al. Evaluation of Augmentation Methods in Classifying Autism Spectrum Disorders from fMRI Data with 3D Convolutional Neural Networks. Diagnostics 2023, 13, 2773. Diagnostics. 2023; 13(23):3545. https://doi.org/10.3390/diagnostics13233545

Chicago/Turabian Style

Giansanti, Daniele. 2023. "AI-Enabled Fusion of Medical Imaging, Behavioral Analysis and Other Systems for Enhanced Autism Spectrum Disorder. Comment on Jönemo et al. Evaluation of Augmentation Methods in Classifying Autism Spectrum Disorders from fMRI Data with 3D Convolutional Neural Networks. Diagnostics 2023, 13, 2773" Diagnostics 13, no. 23: 3545. https://doi.org/10.3390/diagnostics13233545

APA Style

Giansanti, D. (2023). AI-Enabled Fusion of Medical Imaging, Behavioral Analysis and Other Systems for Enhanced Autism Spectrum Disorder. Comment on Jönemo et al. Evaluation of Augmentation Methods in Classifying Autism Spectrum Disorders from fMRI Data with 3D Convolutional Neural Networks. Diagnostics 2023, 13, 2773. Diagnostics, 13(23), 3545. https://doi.org/10.3390/diagnostics13233545

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop